Immunotherapy-based neoadjuvant therapy followed by concurrent chemoradiotherapy in locally advanced and advanced cervical cancer: A real-world study

被引：0
|
作者：
Wei, Qianxue
Qu, Hui
Gong, Tingting
Gao, Song
Tian, Nan
Li, Xiuqin
机构：
[1] China Med Univ, Shengjing Hosp, Dept Gynecol Oncol, Shenyang, Peoples R China
[2] Beigene Beijing Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17509
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy in locally advanced cervical cancer: A multicenter real-world study
    Li, Jiwei
    Wu, Tao
    Cai, Manbo
    Xie, Changjun
    Ding, Sijuan
    Zou, Wen
    Wang, Jingjing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A real-world experience.
    Ruiz-Garcia, Erika
    Cuervo Cmapos, Rogelio
    Carlos Falcon, Juan
    Caderillo-Ruiz, German
    Diaz Romero, Maria del Consuelo
    Herrera, Marytere
    Miyagui-Adame, Sayako Mariana
    Vela, Itzel
    Alvarez, Nora
    Lino-Silva, Leonardo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 62 - 62
  • [3] Feasibility of dose-dense neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced cervical cancer: a real-world experience in the era of the interlace trial
    Schivardi, Gabriella
    Caruso, Giuseppe
    Lapresa, Mariateresa
    Parma, Gabriella
    Lazzari, Roberta
    Vitis, Luigi De
    Stefani, Elena
    Achilarre, Maria Teresa
    Garbi, Annalisa
    Betella, Ilaria
    Aletti, Giovanni
    Maggioni, Angelo
    Zanagnolo, Vanna
    Colombo, Nicoletta
    Multinu, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A127 - A128
  • [4] Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer
    Jakubowicz, J.
    Blecharz, P.
    Skotnicki, P.
    Reinfuss, M.
    Walasek, T.
    Luczynska, E.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (04) : 393 - 399
  • [5] GEMCITABINE FOLLOWED BY CONCURRENT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED PANCREATIC CANCER
    Yasui, H.
    Okazaki, S.
    Tanaka, M.
    Araki, N.
    ANNALS OF ONCOLOGY, 2013, 24
  • [6] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
    Setakornnukul, Jiraporn
    Thephamongkhol, Kullathorn
    BMC CANCER, 2018, 18
  • [7] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
    Jiraporn Setakornnukul
    Kullathorn Thephamongkhol
    BMC Cancer, 18
  • [8] Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: A phase II study
    Benson, Rony
    Pathy, Sushmita
    Kumar, Lalit
    Mathur, Sandeep
    Dadhwal, Vatsla
    Mohanti, Bidhu Kalyan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (06) : 1359 - 1364
  • [9] Neoadjuvant Concurrent Chemoradiotherapy in Treating Locally Advanced Rectal Cancer
    Twu, Chia-Ming
    Wang, Hwei-Ming
    Chen, Joe-Bin
    Chao, Te-Hsin
    Mar, Hsiu-Feng
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2009, 72 (04) : 179 - 182
  • [10] International real-world study of TOTAL neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC).
    Audisio, Alessandro
    Velenik, Vaneja
    Meillat, Helene
    Ruiz-Garcia, Erika
    Martinez, Maria Carmen Riesco
    Dekervel, Jeroen
    Carvalho, Carlos Torres
    Suarez, Francisco Javier
    Kirac, Iva
    Hernando, Jorge
    Artac, Mehmet
    O'Connor, Juan Manuel
    Braam, Petra
    Shamseddine, Ali
    Borelli, Beatrice
    Lopez-Bravo, David Paez
    Dulskas, Audrius
    De Felice, Francesca
    Vanden Bulcke, Alexander
    Sclafani, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 40 - 40
12345